Insulin glargine and lixisenatide Subcutaneous and Syntest D.S.
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Syntest D.S. and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: esterified estrogens / methyltestosterone
Brand name: Covaryx, Covaryx HS, EEMT, EEMT DS, EEMT HS, Essian, Essian HS, Estratest, Estratest HS, Menogen HS, Menogen, Syntest HS, Syntest DS
Synonyms: Esterified estrogens and methyltestosterone, Esterified Estrogens and Methyltestosterone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Syntest H.S.
- Insulin glargine and lixisenatide Subcutaneous-Synthamin 17
- Insulin glargine and lixisenatide Subcutaneous-Synthroid
- Insulin glargine and lixisenatide Subcutaneous-Synthroid Injection
- Insulin glargine and lixisenatide Subcutaneous-Syntocinon
- Insulin glargine and lixisenatide Subcutaneous-Synvexia (Lidocaine and Menthol Cream)
- Syntest D.S.-Insulin glargine, recombinant Subcutaneous
- Syntest D.S.-Insulin glulisine
- Syntest D.S.-Insulin Glulisine (Cartridges and Pens)
- Syntest D.S.-Insulin Glulisine (Vials)
- Syntest D.S.-Insulin glulisine Subcutaneous
- Syntest D.S.-Insulin human inhaled Inhalation